Arrowhead Research reported $-63374000 in Net Income for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Agios Pharmaceuticals AGIO:US $ -88.77M 2.55M
Alnylam Pharmaceuticals ALNY:US $ -204.51M 14.96M
Anika Therapeutics ANIK:US $ 0.56M 5.97M
Arena Pharmaceuticals ARNA:US $ -196.31M 50.22M
Arrowhead Research ARWR:US $ -63374000 33.45M
Bluebird Bio BLUE:US $ -216.82M 24.89M
Cerulean Pharma CERU:US $ -12.67M 3.5M
Dicerna Pharmaceuticals DRNA:US $ -17.07M 23.74M
Intercept Pharmaceuticals ICPT:US $ -3.63M 7.46M
IONIS PHARMACEUT IONS:US $ -82M 1.12M
Ligand Pharmaceuticals LGND:US $ 13.72M 17M
Merk MRK:US $ 4567M 3022M
Mirati Therapeutics MRTX:US $ -80.05M 86.38M
Moderna Inc MRNA:US 3.33B 553M
Nektar Therapeutics NKTR:US $ -129.71M 4.19M
Novartis NOVN:VX SF 2758M 138M
Opko Health OPK:US $ 28.74M 44.92M
Sarepta Therapeutics SRPT:US $ -48.14M 33.26M
Spectrum Pharmaceuticals SPPI:US $ -33.08M 17.05M
Tg Therapeutics TGTX:US $ -85.64M 7.14M
Ultragenyx Pharmaceutical RARE:US $ -73M 49.43M
Vertex Pharmaceuticals VRTX:US $ 851.93M 785M
Xencor XNCR:US $ -40.19M 92.44M
YTE INCY:US $ 181.74M 32.28M